CD44 and breast carcinoma: Since the first identification of CSCs/CICs in breast cancer used a CD44/CD24 marker [15], CICs have been identified in a variety of solid tumors [16,17,18,19,20,21,22,23,24], including colon carcinomas [25,26,27].